Table Of Contents

1. Introduction 15
1.1. Objectives Of The Study 15
1.2. Market Definition 15
1.3. Overview Of North America Microfluidics Market 15
1.4. Currency And Pricing 16
1.5. Limitation 16
1.6. Markets Covered 17
2. Market Segmentation 19
2.1. Markets Covered 19
2.2. Geographic Scope 20
2.3. Years Considered For The Study 21
2.4. Currency And Pricing 21
2.5. Research Methodology 22
2.6. Primary Interviews With Key Opinion Leaders 25
2.7. Secondary Sources 26
2.8. Assumptions 26
3. Market Overview 27
3.1. Drivers 29
3.1.1. Increased Demand Of Poc Testing 29
3.1.2. Wide Range Of Applications In Different Sectors 30
3.1.3. Benefits Associated With Incorporation Of Microfluidics 31
3.1.4. High Return On Investments 32
3.2. Restraints 34
3.2.1. Complexity In Incorporating Microfluidics Technology In The Existing Procedures 34
?
3.3. Opportunities 35
3.3.1. Lucrative Opportunities In Emerging Region 35
3.3.2. Rise In The Drug Discovery Research 37
3.4. Challenges 37
3.4.1. Lack Of Visibility In The Market 37
4. Executive Summary 38
5. Premium Insights 40
6. North America Microfluidics Market, By Component 43
6.1. Overview 44
6.2. Microfluidics Chips 45
6.3. Micropumps 47
6.4. Microneedles 49
6.5. Others 51
7. North America Microfluidics Market, By Material 53
7.1. Overview 54
7.2. Polymer 55
7.3. Glass 57
7.4. Silicon 58
7.5. Others 59
8. North America Microfluidics Market, By Sector 60
8.1. Overview 61
8.2. Healthcare 63
8.2.1. Poc Diagnostics 65
8.2.2. Cell Analysis 65
8.2.3. Drug Discovery 65
8.2.4. Immunoassays 66
8.2.5. Genotyping & Sequencing 66
8.2.6. Microarray Analysis 66
8.2.7. In-Vitro Diagnostics 67
8.2.8. Biomarker Analysis 67
8.2.9. Others 67
8.3. Industrial 68
8.3.1. Biotechnology 69
8.3.2. Energy 70
8.3.3. Nutraceuticals & Food 70
8.3.4. Cosmetics 70
8.3.5. Chemical 71
9. North America Microfluidics Market, By End User 72
9.1. Overview 73
9.2. Hospitals 75
9.3. Research Laboratories & Academia 76
9.4. Industrial R&D 77
10. North America Microfluidics Market, By Geography 78
10.1. North America 78
10.1.1. U.S. 88
10.1.2. Canada 92
10.1.3. Mexico 96
11. North America Microfluidics Market, Company Landscape 100
11.1. Company Share Analysis; North America 100
12. Company Profiles 101
12.1. Perkinelmer Inc. 101
12.1.1. Company Overview 101
12.1.2. Perkinelmer Inc.; Revenue Analysis 102
12.1.3. Product Portfolio 103
12.1.4. Recent Developments 105
12.2. Dolomite Microfluidics 106
12.2.1. Company Overview 106
12.2.2. Dolomite Microfluidics; Company Snapshot 106
12.2.3. Product Portfolio 107
12.2.4. Recent Developments 109
12.3. Microfluidics 111
12.3.1. Company Overview 111
12.3.2. Microfluidics; Company Snapshot 111
12.3.3. Product Portfolio 112
12.3.4. Recent Developments 113
12.4. Abaxis 114
12.4.1. Company Overview 114
12.4.2. Abaxis; Revenue Analysis 114
12.4.3. Product Portfolio 115
12.4.4. Recent Developments 115
12.5. Abbott 116
12.5.1. Company Overview 116
12.5.2. Abbott; Revenue Analysis 116
12.5.3. Product Portfolio 117
12.5.4. Recent Developments 117
12.6. Agilent Technologies 118
12.6.1. Company Overview 118
12.6.2. Agilent Technologies;Revenue Analysis 118
12.6.3. Product Portfolio 119
12.6.4. Recent Developments 119
12.7. Akonni Biosystems Inc. 120
12.7.1. Company Overview 120
12.7.2. Akonni Biosystems, Inc.; Company Snapshot 120
12.7.3. Product Portfolio 121
12.7.4. Recent Developments 121
12.8. Aviva Biosciences 122
12.8.1. Company Overview 122
12.8.2. Aviva Biosciences; Company Snapshot 122
12.8.3. Product Portfolio 122
12.8.4. Recent Developments 122
12.9. Bio-Rad Laboratories Inc. 123
12.9.1. Company Overview 123
12.9.2. Bio-Rad Laboratories, Inc.; Revenue Analysis 123
12.9.3. Product Portfolio 124
12.9.4. Recent Developments 124
12.10. Cepheid 125
12.10.1. Company Overview 125
12.10.2. Cepheid; Company Snapshot 125
12.10.3. Product Portfolio 125
12.10.4. Recent Developments 125
12.11. Fluxion Bioscience 126
12.11.1. Company Overview 126
12.11.2. Fluxion Bioscience; Company Snapshot 126
12.11.3. Product Portfolio 127
12.11.4. Recent Developments 127
12.12. Hewlett-Packard 128
12.12.1. Company Overview 128
12.12.2. Hp Inc.; Revenue Analysis 128
12.12.3. Product Portfolio 129
12.12.4. Recent Developments 129
12.13. Illumina Inc. 130
12.13.1. Company Overview 130
12.13.2. Illumina, Inc.;Revenue Analysis 130
12.13.3. Product Portfolio 131
12.13.4. Recent Developments 131
12.14. Raindance Technologies Inc. 132
12.14.1. Company Overview 132
12.14.2. Raindance Technologies, Inc.; Company Snapshot 132
12.14.3. Product Portfolio 133
12.14.4. Recent Developments 133
12.15. Thermo Fisher Scientific Inc. 134
12.15.1. Company Overview 134
12.15.2. Thermo Fisher Scientific Inc. ;Revenue Analysis 134
12.15.3. Product Portfolio 135
12.15.4. Recent Developments 135
13. Related Reports 136